The biopharma industry is in need of talented minds to take promising pipelines to the clinic and beyond. Venture capitalists have nominated prominent founders and entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. These entrepreneurs have proven their expertise in hitting milestones, be it in the lab or…
A new wave of biomimicry companies is harnessing the power of nature to develop innovative treatments for various diseases. By studying the properties of plants and animals, these companies are creating novel therapeutic targets and drugs that mimic natural protective mechanisms. From tick saliva to snake venom, these biomimicry companies are unlocking the secrets of…
The biopharma industry is witnessing a surge in investment in the immunology field, with over 10 buyouts of immunology and inflammation (I&I) drug developers this year. Several biotech companies have raised impressive funds to advance the development of their immunology-related research and development (R&D). These companies are working on innovative treatments for various diseases, including…
